Frailty, Physical Performance, and Molecular Changes in Older Adults Participating in Different Exercise Programs: A 12-Week Preference-Based Non-Randomized Study
Nutrients · 2026
DOI: 10.3390/nu18183052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2026. Verfasst von Jiahao Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing 100084, China. Hauptthemen laut MEDLINE: Frailty, Resistance Training, Frail Elderly, Physical Functional Performance. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, National Key Research and Development Program of China, Shenzhen Key Laboratory of Neurogenomics.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Multidimensional evidence on exercise participation and frailty in older adults is limited.
Methods
This 12-week preference-based, non-randomized study included 145 participants (mean age 82.25 years): walking (n = 50), resistance training (n = 20), Traditional Chinese exercise (n = 23), and control (n = 52). Frailty was the primary outcome; physical-performance and molecular analyses were exploratory. Paired trajectories, baseline-stratified binary transitions, and adjusted associations were examined.
Results
Among paired participants, pre-frailty/frailty prevalence changed from 70.0% to 60.0% with walking, 90.0% to 70.0% with resistance training, 50.0% to 63.6% with Traditional Chinese exercise (n = 22), and 50.0% to 69.2% in controls. Baseline status constrained opportunities for binary improvement or deterioration. All adjusted frailty risk-ratio confidence intervals included 1. Walking was associated with faster Timed Up and Go and Five-Yard Walk Test performance after correction across eight outcomes. Molecular changes also occurred in controls; intervention timing and potential laboratory-batch confounding limited between-group interpretation. No microbiome taxon survived multiplicity correction; small paired samples limited precision.
Conclusions
Walking and resistance-training groups showed descriptively more favorable prevalence trajectories, but adjusted frailty comparisons remained inconclusive. These findings do not establish frailty prevention, modality superiority, or exercise-specific molecular mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Sports Medicine and Rehabilitation, Beijing Sport University, Beijing 100084, China.
- Shenzhen Key Laboratory of Neurogenomics, BGI-Shenzhen, Shenzhen 518120, China.
- State Key Laboratory of Genome and Multi-Omics Technologies, BGI Research, Shenzhen 518083, China.
- Key Laboratory of Sports and Physical Fitness of the Ministry of Education, Beijing Sport University, Beijing 100084, China.
ORCID-Profile: Jiahao Li, Huizhi Yang, Yifan Lu
Förderung
- the National Key Research and Development Program of China
- National Key Research and Development Program of China
- Shenzhen Key Laboratory of Neurogenomics
Zitieren
APA
Li, J., Yang, H., Zhen, H., Li, Z., Lu, J., Yan, H., Nie, C., & Lu, Y. (2026). Frailty, Physical Performance, and Molecular Changes in Older Adults Participating in Different Exercise Programs: A 12-Week Preference-Based Non-Randomized Study. Nutrients. https://doi.org/10.3390/nu18183052
Vancouver
Li J, Yang H, Zhen H, Li Z, Lu J, Yan H, et al. Frailty, Physical Performance, and Molecular Changes in Older Adults Participating in Different Exercise Programs: A 12-Week Preference-Based Non-Randomized Study. Nutrients. 2026. doi:10.3390/nu18183052
BibTeX
@article{Li2026,
author = {Li, Jiahao and Yang, Huizhi and Zhen, Hefu and Li, Zhiming and Lu, Jiali and Yan, Huiping and Nie, Chao and Lu, Yifan},
title = {Frailty, Physical Performance, and Molecular Changes in Older Adults Participating in Different Exercise Programs: A 12-Week Preference-Based Non-Randomized Study},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18183052}
}
EUVIMED